Similarly, as recommended by [14], small “daily doses” of PA associated with reductions in sedentary behavior, such as a decrease in sitting time, are capable of modestly attenuating post-prandial plasma glucose and insulin concentrations, particularly in individuals with insulin resistance and a high BMI. The gene discussed is INS; the disease is Insulin resistance.